ParaTechs

ParaTechs is a specialized biotechnology tools and services company serving the preclinical research market. Its primary business segments are Assisted Reproductive Technology (ART) products for rodents, which provide non-surgical alternatives to traditional techniques, and protein expression technologies via its VE-BEVS baculovirus system. The company generates revenue through direct product sales and a comprehensive menu of contract research services, including sperm/embryo cryopreservation, rederivation, and grant writing support. Founded on IP from the University of Kentucky, it is a private, niche player enabling more efficient and humane animal research.

Non-surgical Embryo Transfer (NSET) devices for rodents; VE-BEVS baculovirus expression system for recombinant protein production.

ParaTechs competes in the niche market of rodent ART tools against traditional surgical methods and potentially other non-surgical devices. In protein expression, it competes with other baculovirus and eukaryotic expression systems from major reagent suppliers. Its contract services face competition from CROs and specialized academic core facilities.